Skip to content
easybpt
Browse topics

Haematology

Thrombophilia

Inherited and acquired thrombophilias, who to test and when (ASH 2023, BSH 2022), drug and timing effects on the assays, antiphospholipid syndrome and why it rules out most DOACs, and contraception and pregnancy decisions.

Tier 1Condition

Written with AI assistance and fact-checked against the sources below. For exam study, not clinical decisions. How notes are made

3 questions9 flashcards

At a glance

  • Thrombophilia is a laboratory tendency to thrombosis. Most people with a heritable thrombophilia never clot, and most VTE occurs without one.
  • Test only if the result will change management. ASH 2023, BSH 2022 and the 2019 THANZ VTE guideline all advise against routine testing.
  • Anticoagulation duration after VTE depends mainly on whether the clot was provoked, not on heritable thrombophilia results.

Loading the rest of the note…

Finished reading?

Test yourself on it:3 questions9 flashcards

Sources

Last updated
14 November 2026
What changed
  • 14 November 2026 Personal emails, About story and Australian-style copy

Send feedback

Type of feedback

The page you're on and your device type are attached automatically.